Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cellsBAKHEET, S. A; ATTIA, S. M; AL-RASHEED, N. M et al.Mutagenesis. 2011, Vol 26, Num 4, pp 533-543, issn 0267-8357, 11 p.Article

Prophylactic Use of Pegfilgrastim in Patients Treated with a Nitrosourea and Teniposide for Recurrent GliomaTHIEPOLD, Anna-Luisa; LEMERCIER, Sophie; FRANZ, Kea et al.Pharmacotherapy. 2014, Vol 34, Num 6, pp 633-642, issn 0277-0008, 10 p.Article

Seasonal Variations in the Deoxypodophyllotoxin Content and Yield of Anthriscus sylvestris L. (Hoffm.) Grown in the Field and under Controlled ConditionsHENDRAWATI, Oktavia; WOERDENBAG, Herman J; HILLE, Jacques et al.Journal of agricultural and food chemistry (Print). 2011, Vol 59, Num 15, pp 8132-8139, issn 0021-8561, 8 p.Article

Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588)ETTINGER, David S; FINKELSTEIN, Dianne M; RITCH, Paul S et al.Lung cancer. 2002, Vol 37, Num 3, pp 311-318, issn 0169-5002, 8 p.Article

Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cellsMORGAN, Susan E; RYUNGSA KIM; PU CHEN WANG et al.Oncogene (Basingstoke). 2000, Vol 19, Num 43, pp 5010-5019, issn 0950-9232Article

t(3;11) translocation in treatment-related acute myeloid leukemia fuses MLL with the GMPS (GUANOSINE 5' MONOPHOSPHATE SYNTHETASE) genePEGRAM, Linda D; MEGONIGAL, Maureen D; LANGE, Beverly J et al.Blood. 2000, Vol 96, Num 13, pp 4360-4362, issn 0006-4971Article

Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission : A Pediatric Oncology Group studyBUCHANAN, G. R; RIVERA, G. K; POLLOCK, B. H et al.Cancer. 2000, Vol 88, Num 5, pp 1166-1174, issn 0008-543XArticle

Elevation of micronuclei frequency in mouse bone marrow treated with various doses of teniposide (VM-26)JAGETIA, G. C; ARUNA, R.Toxicology letters. 1999, Vol 104, Num 3, pp 203-210, issn 0378-4274Article

Effect of teniposide (VM-26) on the cell survival, micronuclei-induction and lactate dehydrogenase activity on V79 cellsSATISH KUMAR ADIGA; GANESH CHANDRA JAGETIA.Toxicology (Amsterdam). 1999, Vol 138, Num 1, pp 29-41, issn 0300-483XArticle

Non-Hodgkin lymphoma (NHL) as a second neoplasm occurring after neuroblastoma treatmentSIEGERT, E; WEISSBACH, G; FISCHER, R et al.Medical and pediatric oncology. 1998, Vol 30, Num 1, pp 18-21, issn 0098-1532Article

New agents in the treatment of small cell lung cancerGHAEMMAGHAMI, M; JETT, J. R.Chest. 1998, Vol 113, Num 1, pp 86S-91S, issn 0012-3692, SUPConference Paper

A phase II study of VM-26 plus lonidamine in pretreated small cell lung cancerGRIDELLI, C; DE MARINIS, F; DI GIACOMO, R et al.Anticancer research. 1997, Vol 17, Num 2B, pp 1277-1279, issn 0250-7005Article

Molecular cytogenetic evaluation of the aneugenic effects of teniposide in somatic and germinal cells of male miceATTIA, Sabry M.Mutagenesis. 2012, Vol 27, Num 1, pp 31-39, issn 0267-8357, 9 p.Article

Synthesis and comparative evaluation of 4-oxa- and 4-aza-podophyllotoxins as antiproliferative microtubule destabilizing agentsCHERNYSHEVA, Natalia B; TSYGANOV, Dmitry V; PHILCHENKOV, Alex A et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 7, pp 2590-2593, issn 0960-894X, 4 p.Article

Chemical Stability of Teniposide in Aqueous and Parenteral Lipid EmulsionsJING WANG; YUE CUI; XING TANG et al.Drug development and industrial pharmacy. 2009, Vol 35, Num 4, pp 508-513, issn 0363-9045, 6 p.Article

Chemotherapy as treatment of primary and recurrent small cell lung cancerSCHUETTE, Wolfgang.Lung cancer. 2001, Vol 33, pp S99-S107, issn 0169-5002, SUP1Conference Paper

Topoisomerase II cleavable complex formation within DNA loop domainsLAMBERT, J. M; FERNANDES, D. J.Biochemical pharmacology. 2000, Vol 60, Num 1, pp 101-109, issn 0006-2952Article

The American mayapple revisited : Podophyllum peltatum-still a potential cash crop?MORAES, Rita M; BURANDT, Charles JR; GANZERA, Markus et al.Economic botany. 2000, Vol 54, Num 4, pp 471-476, issn 0013-0001Article

Effects of neoplastic transformation and teniposide (VM26) on protein kinase C isoform expression in rodent fibroblastsQING YAN LIU; CARSON, C; RIBECCO, M et al.Cancer letters. 2000, Vol 153, Num 1-2, pp 13-23, issn 0304-3835Article

Correlation between cell survival, micronuclei-induction, and LDH activity in V79 cells treated with teniposide (VM-26) before exposure to different doses of γ radiationSATISH KUMAR ADIGA; GANESH CHANDRA JAGETIA.Toxicology letters. 1999, Vol 109, Num 1-2, pp 31-41, issn 0378-4274Article

The vascular compartment hampers accurate determination of teniposide penetration into brain tumor tissueVAN TELLINGEN, O; BOOGERD, W; NOOIJEN, W. J et al.Cancer chemotherapy and pharmacology. 1997, Vol 40, Num 4, pp 330-334, issn 0344-5704Article

Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapyGALLIE, B. L; BUDNING, A; DEBOER, G et al.Archives of ophthalmology (1960). 1996, Vol 114, Num 11, pp 1321-1328, issn 0003-9950Article

Nimustine (ACNU) Plus Teniposide (VM26) in Recurrent GlioblastomaGLAS, M; HUNDSBERGER, T; STUPLICH, M et al.Oncology. 2009, Vol 76, Num 3, pp 184-189, issn 0030-2414, 6 p.Article

Multidrug Resistance-Associated Protein-Overexpressing Teniposide-Resistant Human Lymphomas Undergo Apoptosis by a Tubulin-Binding AgentANEJA, Ritu; MIN LIU; YATES, Clayton et al.Cancer research (Baltimore). 2008, Vol 68, Num 5, pp 1495-1503, issn 0008-5472, 9 p.Article

Camptothecin and podophyllotoxin derivatives : Inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profileHARTMANN, Jörg T; LIPP, Hans-Peter.Drug safety. 2006, Vol 29, Num 3, pp 209-230, issn 0114-5916, 22 p.Article